BOLOGNA, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 6.474
EU - Europa 4.163
AS - Asia 2.051
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
SA - Sud America 8
AF - Africa 3
Totale 12.721
Nazione #
US - Stati Uniti d'America 6.460
IE - Irlanda 1.253
CN - Cina 1.081
TR - Turchia 853
SE - Svezia 690
DE - Germania 534
GB - Regno Unito 434
UA - Ucraina 418
IT - Italia 363
FI - Finlandia 229
FR - Francia 162
IN - India 45
SG - Singapore 44
BE - Belgio 24
CA - Canada 13
RU - Federazione Russa 13
EU - Europa 11
CZ - Repubblica Ceca 8
NL - Olanda 8
AU - Australia 7
BR - Brasile 7
KR - Corea 7
IL - Israele 6
ES - Italia 4
MA - Marocco 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
HU - Ungheria 2
JP - Giappone 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
ME - Montenegro 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
UZ - Uzbekistan 1
Totale 12.721
Città #
Jacksonville 1.671
Chandler 1.324
Dublin 1.251
Izmir 419
Nanjing 349
San Mateo 334
Boardman 328
Wilmington 258
Lawrence 209
Princeton 209
Ann Arbor 194
New York 157
Nanchang 123
Milan 102
Beijing 96
Woodbridge 93
Bremen 83
Seattle 83
Shenyang 83
Ashburn 73
Verona 71
Hebei 58
Des Moines 56
Mountain View 53
Jiaxing 52
Kunming 47
L'aquila 46
Tianjin 45
Changsha 31
Ningbo 30
Singapore 27
Jinan 26
Dearborn 24
Falls Church 24
Brussels 23
Helsinki 23
Norwalk 23
Philadelphia 22
Los Angeles 18
Guangzhou 17
Shanghai 17
Taizhou 17
Hangzhou 16
Strasbourg 15
Lanzhou 14
Pune 14
Zhengzhou 13
Torre Del Greco 12
Düsseldorf 11
Tappahannock 11
Fremont 9
Auburn Hills 6
Belfast 6
Brno 6
Changchun 6
Hefei 6
Toronto 6
Venezia 6
Pescara 5
Shaoxing 5
Ancona 4
Houston 4
London 4
Napoli 4
Pavia 4
Redmond 4
Wuhan 4
Delhi 3
Florence 3
Fuzhou 3
Hanover 3
L’Aquila 3
Miglianico 3
Rome 3
San Francisco 3
Turin 3
Abu Dhabi 2
Apice 2
Belgrade 2
Budapest 2
Casoria 2
Ceprano 2
Chisinau 2
Cicciano 2
Clifton 2
Dhaka 2
Fairfield 2
Haikou 2
Jinhua 2
Karaikal 2
Lanciano 2
Lugones 2
Madrid 2
Melbourne 2
Munich 2
Naples 2
Orange 2
Ottawa 2
Phoenix 2
Redwood City 2
Totale 8.459
Nome #
ANTIANDROGENS AND 5-ALPHA REDUCTASE INHIBITION OF THE PROLIFERATION RATE IN PC3 AND DU145 HUMAN PROSTATIC-CANCER CELL-LINES 103
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 102
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 92
Serum 25(OH)D seasonality in urologic patients from central Italy 92
THE PROSTATIC MASSAGE YELDS VIABLE PROSTATIC EPITHELIAL CELLS AND MAY ALLOW AND EARLY DIAGNOSIS OF PROSTATIC CANCER IN VITRO 90
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 89
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 88
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 84
Obesity in the elderly - On the role of adipokines in prostate cancer progression 80
PROTEASE PRODUCTION (Upa AND METALLOPROTEINASES MMP-9) IN SHORT TERM CULTURE OF PROSTATIC CARCINOMA, CAN HAVE IMPORTANT DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS. 80
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 80
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors 79
Human prostatic carcinoma in tissue culture: Correlations between histological diagnosis and in vitro parameters 79
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 77
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 77
Specific neurons of bran cortex and cerebellum are PIPPin-positive 77
Ricerche preliminari sull'azione del Desametazone e del Diflunisal nella flogosi sperimentale 77
Early diagnosis of prostatic carcinoma may be achieved through in vitro culture of tumor cells harvested by prostatic massage 77
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 77
Osteoblast-derived TGF beta-1 modulates matrix degrading protease expression and activity in prostate cancer cells (vol 85, pg 407, 2000) 77
Imipenem concentrations in human prostatic tissue: Clinical implications 77
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 76
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 75
Mitogen dose-dependent effect of weak pulsed electromagnetic field on lymphocyte blastogenesis. 75
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 75
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-9) PRODUCTION IS IN-CREASED IN SHORT TERM CULTURES OF HUMAN PROSTATIC CARCINOMA. 75
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells 74
Stimulatory effect of hr tumor necrosis factor on TxB2 release by polymorphonuclears and macrophages. 74
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 73
Validity and limitations of a bimodal parametric approach for the evaluation of antibody affinity distributions 73
Early diagnosis of prostatic carcinoma based on in vitro culture of viable tumor cells harvested by prostatic massage 73
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 73
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 73
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 73
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 73
APOPTOSI E CANCRO DELLA PROSTATA 73
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 73
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 72
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 72
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 72
INIBITORI DI METALLOPROTEASI DI MATRICE: PROSPETTIVE TERAPEUTICHE. EOS - JOURNAL OF IMMUNOLOGY AND IMMUNOPHARMACOLOGY, VOL.XXI – 2001 – N.1: 22-27 72
Stimulatory effect of hr tumor necrosis factor on TXB2 release by polymorphnuclears and macrophages 72
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer 72
BOMBESIN- LIKE IMMUNOREACTIVE CELLS IN THE GENITAL SYSTEM OF ADULT MALE AND FEMALE RATS 72
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 72
Agar-specimen orientation technique revisited: a simple and effective method in histopathology 72
ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PROSTATIC-CARCINOMA CELL STRAIN OBTAINED FROM EXFOLIATED TUMOR-CELLS AFTER PROSTATIC MASSAGE 71
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 71
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 71
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma 71
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 71
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 71
Akt protein expression and activation in naive and antihormonal treated prostate cancer tissues 71
Changes in the immune response in the mouse following thermal shock. I. Humoral immunity 71
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 70
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 70
Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis 70
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 69
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 69
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 69
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 69
Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography 69
Type 5 Phosphodiesterase (PDE5) Expression in Human Vagina 69
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 69
Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 Prostate Cancer Cell Line 68
Synergistic activation of natural-killer activity by human recombinant interferon-alpha or interferon-gamma and indomethacin. 68
Introductory Immunology 68
In vivo efficacy of HER1/EGFR tyrosine kinase inhibition in erlotinib resistant PC3 prostate cancer cells is associated to reduced endothelial cell organization and increased inflammatory infiltration 67
NEW 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-D] PYRIMIDINE AND PYRROLO [2,3-D] PYRIMIDINE AND USES THEREOF 67
An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines 67
Isolation of homogenous antibody populations by affinity chromatography 67
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors 66
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells 66
"Trattamento della rinite allergica perenne (Dpt) con terapia iposensibilizzante a dose unica" 66
Reactivation of androgen receptor and Fas: FASL signalling pathways by azacitidine treatment sensitizes aggressive prostate cancers to hormone manipulation and chemotherapy 66
FINASTERIDE DOSE-DEPENDENCY REDUCES THE PROLIFERATION RATE OF THE LNCAP HUMAN PROSTATIC-CANCER CELL-LINE IN-VITRO 65
“A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis” 65
L'aumento di neurotrofine è associato alla progressione del tumore della prostata in un modello animale murino 65
Biotargets of Cancer in Current Clinical Practice 65
ATTIVITA’ CHEMIOTATTICA DEGLI OSTEOCLASI, TGF-BETA 1 MEDIATA, SU CELLULE DI CARCINOMA PROSTA-TICO IN VITRO 65
Anti-hormone treatments increase Akt protein expression and activation in prostate cancer 64
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 64
Norfloxacin concentrations in seminal plasma measured by HPLC 64
LA RIDONDANZA DELLE VIE DI SEGNALAZIONE INTRACELLULARI PI3K-AKT-MTOR INDUCE LA RESISTENZA DI CELLULE DI CANCRO PROSTATICO ALLA TERAPIA ORMONALE ED A CHEMOTERAPICI IN VIVO ED IN VITRO 64
Inhibition of tyrosine kinase c-Src improves experimental breast cancer metastatic disease. Implication for therapy 64
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures 63
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models 63
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 63
Ruolo della finasteride nel controllo della proliferazione di colture primarie di carcinoma della prostata 63
Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures 63
Improved tissue culture method for the study of prostatic carcinoma: a significant diagnostic tool 63
Effect of hrTNFalpha on TXB2 release by macrphages 63
Characterization of prostate cancer DU145 cells expressing the recombinant androgen receptor 63
In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin 63
Reactivation of androgen receptor and Fas:Fasl signaling pathways by Azacitidine treatment sensitizes aggressive prostate cancer to hormone manipulation and chemotherapy 63
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice 63
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 62
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells 62
Surgical and Biologic Outcomes After Neoadjuvant Bicalutamide Treatment in Prostate Cancer 62
Co-evolution of stroma and neoplastic cells in prostate cancer is sustained by reprogramming energy metabolism 62
Totale 7.166
Categoria #
all - tutte 44.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.758 416 6 216 17 8 250 309 20 229 43 15 229
2020/20211.801 36 216 5 226 217 76 232 9 224 86 398 76
2021/20221.353 89 160 266 91 59 15 17 82 66 37 93 378
2022/20233.927 284 159 61 370 467 455 3 259 1.671 31 102 65
2023/2024774 127 53 47 181 56 190 18 40 1 18 10 33
2024/202532 32 0 0 0 0 0 0 0 0 0 0 0
Totale 12.810